全文获取类型
收费全文 | 10187篇 |
免费 | 1034篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 126篇 |
儿科学 | 322篇 |
妇产科学 | 189篇 |
基础医学 | 1216篇 |
口腔科学 | 135篇 |
临床医学 | 1333篇 |
内科学 | 1805篇 |
皮肤病学 | 133篇 |
神经病学 | 1153篇 |
特种医学 | 256篇 |
外科学 | 1386篇 |
综合类 | 75篇 |
一般理论 | 9篇 |
预防医学 | 975篇 |
眼科学 | 216篇 |
药学 | 783篇 |
1篇 | |
中国医学 | 6篇 |
肿瘤学 | 1114篇 |
出版年
2023年 | 55篇 |
2022年 | 86篇 |
2021年 | 240篇 |
2020年 | 140篇 |
2019年 | 210篇 |
2018年 | 271篇 |
2017年 | 227篇 |
2016年 | 228篇 |
2015年 | 251篇 |
2014年 | 379篇 |
2013年 | 485篇 |
2012年 | 706篇 |
2011年 | 719篇 |
2010年 | 361篇 |
2009年 | 368篇 |
2008年 | 499篇 |
2007年 | 493篇 |
2006年 | 525篇 |
2005年 | 474篇 |
2004年 | 437篇 |
2003年 | 359篇 |
2002年 | 309篇 |
2001年 | 180篇 |
2000年 | 204篇 |
1999年 | 156篇 |
1998年 | 83篇 |
1997年 | 71篇 |
1996年 | 59篇 |
1995年 | 64篇 |
1993年 | 62篇 |
1992年 | 174篇 |
1991年 | 146篇 |
1990年 | 172篇 |
1989年 | 147篇 |
1988年 | 140篇 |
1987年 | 146篇 |
1986年 | 133篇 |
1985年 | 128篇 |
1984年 | 103篇 |
1983年 | 91篇 |
1982年 | 63篇 |
1981年 | 61篇 |
1980年 | 61篇 |
1979年 | 88篇 |
1978年 | 84篇 |
1977年 | 82篇 |
1976年 | 63篇 |
1974年 | 83篇 |
1973年 | 82篇 |
1970年 | 56篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Growth Hormone Induces Recurrence of Infantile Hemangiomas After Apparent Involution: Evidence of Growth Hormone Receptors in Infantile Hemangioma
下载免费PDF全文
![点击此处可从《Pediatric dermatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Naikhoba C. O. Munabi B.A. Qian Kun Tan H.S. Maria C. Garzon M.D. Gerald G. Behr M.D. Carrie J. Shawber Ph.D. June K. Wu M.D. 《Pediatric dermatology》2015,32(4):539-543
Infantile hemangiomas (IHs) are the most common benign tumor of infancy, characterized by a natural history of early proliferation in the first months of life to eventual involution during childhood, often with residual fibrofatty tissue. Once involution has been achieved, IHs do not typically recur. We present two cases of exogenous growth hormone therapy resulting in the recurrence of IHs in late childhood, supported by radiological, immunohistochemical, in vitro, and in vivo evidence. 相似文献
4.
Daniel J. Snyder Thomas R. Kroshus Aakash Keswani Evan B. Garden Karl M. Koenig Kevin J. Bozic David S. Jevsevar Jashvant Poeran Calin S. Moucha 《The Journal of arthroplasty》2019,34(4):613-618
Background
Nursing Home Compare (NHC) ratings, created and maintained by Medicare, are used by both hospitals and consumers to aid in the skilled nursing facility (SNF) selection process. To date, no studies have linked NHC ratings to actual episode-based outcomes. The purpose of this study was to evaluate whether NHC ratings are valid predictors of 90-day complications, readmission, and bundle costs for patients discharged to an SNF after primary total joint arthroplasty (TJA).Methods
All SNF-discharged primary TJA cases in 2017 at a multihospital academic health system were queried. Demographic, psychosocial, and clinical variables were manually extracted from the health record. Medicare NHC ratings were then collected for each SNF. For patients in the Medicare bundle, postacute and total bundle cost was extracted from claims.Results
Four hundred eighty-eight patients were discharged to a total of 105 unique SNFs. In multivariate analysis, overall NHC rating was not predictive of 90-day readmission/major complications, >75th percentile postacute cost, or 90-day bundle cost exceeding the target price. SNF health inspection and quality measure ratings were also not predictive of 90-day readmission/major complications or bundle performance. A higher SNF staffing rating was independently associated with a decreased odds for >75th percentile 90-day postacute spend (odds ratio, 0.58; P = .01) and a 90-day bundle cost exceeding the target price (odds ratio = 0.69; P = .02) but was similarly not predictive of 90-day readmission/complications.Conclusion
Results of our study suggest that Medicare's NHC tool is not a useful predictor of 90-day costs, complications, or readmissions for SNFs within our health system. 相似文献5.
6.
7.
8.
9.
10.